The U.S. Department of Health and Human Services (HSS) has appointed endodontist Lawrence A. Tabak, DDS, PhD, as acting director of the National Institutes of Health (NIH). Tabak will lead the agency in an interim capacity until a…

As we enter the third year of the global pandemic with new COVID-19 cases skyrocketing to the highest numbers ever recorded, some public health experts suggest metrics should no longer hinge on case counts but rather on the number of…

With the United States reporting nearly 1 million new COVID-19 cases—smashing through previous records—on January 3, the federal government has subsequently increased its initial order of Pfizer’s antiviral medication by 10 million.…

The United States Food and Drug Administration approved a booster shot of the Pfizer COVID-19 vaccine for children ages 12 to 15. Previously, the Pfizer booster was only available to those ages 16 and older. Pfizer is the only COVID-19…

As the United States sees the highest case numbers ever since the global pandemic began, South Africa offers some hope. While the nation endured a fourth wave of COVID-19 with the highly transmissible Omicron variant—which sent case numbers…

Even though dental practices were shuttered during March and April of 2020, the American Dental Association (ADA) Health Policy Institute found that dental spending only decreased by 1.8% from 2020 to 2021. The per capita spending was…

Research from the National Institutes of Health shows that not only can the novel coronavirus last for months within human organs, it can infect the heart and lungs within days of initial infection. With the United States and nations across…

On December 27, the United States Centers for Disease Control and Prevention (CDC) recommended that the isolation time required after an asymptomatic COVID-19 infection and quarantine time needed after exposure to a person with COVID-19 be…

As COVID-19’s Omicron variant rages through the United States, with surging cases across almost every region, some public health experts suggest that steeply rising case numbers are no longer the best way to evaluate the status of the…

The use of statins, blood thinners, and antidepressants is ubiquitous across the United States; however, these drugs may pose risks when taken in conjunction with the new antiviral medications that treat COVID-19. The COVID-19…